Amnion Derived Stem Cell Activator Injections

Obtaining stem cells from embryos is considered by many groups to be unethical, but obtaining stem cells and regenerative material from amniotic fluid is not affected by this ethical debate.

Amniotic fluid is normally disposed of after.birth, so using it in order to obtain amniotic derived stem cell activator injections does not affect the embryo in any way.

There is no harm to the fetus and no blood from the fetus is used, only the amniotic fluid that would be discarded anyway.

Amniotic fluid contains multiple excellent properties for promoting tissue regeneration and repair:

1. 1. 1. 1. They have important anti-inflammatory properties including cytokines that help relieve pain. There is no steroid component to amniotic derived injections.
         2. The fluid contains growth factors which can help promote new tissue growth and also help to call in the body’s stem cells.
         3. Amniotic Fluid contains hyaluronic acid. This is also a prominent component of joint fluid, and is important for lubricating cartilage and promoting growth of new cartilage. Hyaluronic acid is the main component of viscosupplementation injections with Synvisc and Hyalgan medicines. They have been shown to provide excellent pain relief for upwards of six to twelve months.
         4. Amniotic Fluid is an amazing source of concentrated stem cell activators. Thankfully, the fluid does not cause an immune or rejection reaction when injected into a patient.

Amniotic stem cell rich treatments have been great for difficult wounds, such as in diabetics.

Amniotic membranes have been used extensively in plastic surgery for treating wounds that have been difficult to heal, as well as opthalmology for helping to heal corneal injury. Amniotic derived stem cell activator injections have been successfully used to promote spinal fusion during surgery, and as a scar barrier around the spinal cord.

Amniotic derived stem cell activator injections have been used over 10,000 times in the US with no reported adverse events, and hundreds of thousands of times in Europe and abroad. There are plenty of anecdotal reports regarding the use of amnion for treating tendinosis and tendinitis of the rotator cuff and elbow tendons. This includes both golfer’s elbow and tennis elbow. Results from these reports have been very promising.

Additionally, anecdotal reports on the use of amnion for joint arthritis in both the spine and extremities has also been encouraging. Surgeons have started using the amnion to supplement surgical repair and reconstruction of ACL’s, Achilles tendons and rotator cuff tendons.

Amniotic derived stem cell activator injections are considered experimental by the FDA. None of the material on this website has been evaluated by the FDA, and no claims are being made. Outcomes vary between individuals.

Studies carried on so far show very promising results. No FDA clinical trials have been performed however.

Recent research has focused on using human amniotic membranes for various indications. Surgical placement of amniotic tissue at the site of laminectomy in canines helped reduce scar tissue significantly. (Tao 2009).

Amniotic fluid rich stem cell medicine offers regenerative potential, anti-inflammation, growth factors and hyaluronic acid.

In a human report, using a human amnion tissue patch after a right l4-5 decompression procedure significantly reduced both scar tissue formation and adherence to the underlying dura (ploska, applied biologics 2012).

R3 Stem Cell is investigating regenerative therapies with an Institutional Review Board (IRB) approved study for several condition categories. Since we do NOT have FDA clinical trial results available, this data will come in very handy in moving the field forward. To read more about the investigational study, visit the information on ClinicalTrials.gov:

Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions